Bath & Body Works, Inc. (NYSE:BBWI) Receives $42.19 Average Target Price from Analysts

Key Points

• Bath & Body Works, Inc. received an average rating of "Moderate Buy" from analysts, with 14 buy recommendations and a 12-month price target of $42.19.
• Recent adjustments to price targets include JPMorgan raising it from $40.00 to $46.00, while Goldman Sachs and Raymond James lowered their targets to $43.00 and $37.00, respectively.
• The company reported a quarterly net margin of 11.10% and a dividend yield of 2.8%, reflecting a strong performance on earnings despite lower revenue compared to estimates.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eighteen analysts that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $42.1875.

Several equities research analysts have recently issued reports on the company. Citigroup raised their price target on Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Telsey Advisory Group reissued an "outperform" rating and set a $38.00 target price (down from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. Raymond James Financial decreased their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. Morgan Stanley decreased their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of BBWI. Wealth Enhancement Advisory Services LLC raised its position in Bath & Body Works by 38.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after purchasing an additional 11,681 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new position in Bath & Body Works in the 4th quarter worth approximately $258,000. Merit Financial Group LLC bought a new position in Bath & Body Works in the 1st quarter worth approximately $714,000. Nuveen Asset Management LLC raised its position in Bath & Body Works by 3.7% in the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after purchasing an additional 27,136 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after buying an additional 1,606,988 shares during the period. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded up $0.74 during midday trading on Friday, hitting $28.91. The company's stock had a trading volume of 1,246,297 shares, compared to its average volume of 5,133,928. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of 7.72, a PEG ratio of 0.94 and a beta of 1.54. The stock's 50 day simple moving average is $29.81 and its 200 day simple moving average is $31.81. Bath & Body Works has a fifty-two week low of $24.94 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The firm's revenue was up 2.9% compared to the same quarter last year. During the same period last year, the business posted $0.38 earnings per share. As a group, analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a $0.20 dividend. The ex-dividend date was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.8%. Bath & Body Works's payout ratio is 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.